1. Pharmacologic Treatment of Heart Failure due to Ventricular Dysfunction by Myocardial Stunning

   • Martín J. García González
   • Alberto Domínguez Rodríguez

   Current Opinion 20 September 2012 Pages: 69 - 75

   

2. Mechanisms, Manifestations, and Management of Digoxin Toxicity in the Modern Era

   • Jerry L. Bauman
   • Robert J. DiDomenico
   • William L. Galanter

   Therapy In Practice 20 September 2012 Pages: 77 - 86

   

3. Preventing Cardiovascular Disease in the 21st Century

   • Martha L. Daviglus
   • Donald M. Lloyd-Jones
   • Amber Pirzada

   Review Article 20 September 2012 Pages: 87 - 101

   

4. A Review of the Efficacy of Fixed-Dose Combinations Olmesartan Medoxomil/ Hydrochlorothiazide and Amlodipine Besylate/ Benazepril in Factorial Design Studies

   • Allen Quan
   • Kathleen Chavanu
   • Jennifer Merkel

   Review Article 20 September 2012 Pages: 103 - 113

   

5. The Effects of HMG-CoA Reductase Inhibitors on Endothelial Function

   • Belay Tesfamariam

   Review Article 20 September 2012 Pages: 115 - 120

   

6. Lipid Management and Cholesterol Goal Attainment in Norway

   • Leiv Ose
   • Finn E. Skjeldestad
   • Linus Jönsson

   Original Research Article 20 September 2012 Pages: 121 - 128

   

7. Cost Effectiveness of Biventricular Pacemakers in Heart Failure Patients

   • Adrienne Heerey
   • Michael Lauer
   • Karen James

   Original Research Article 20 September 2012 Pages: 129 - 137